Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.85NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.2.65NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BG.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.2.61NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.2.74NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.38.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BF.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BT.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.2.55NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.76NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.30NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BA.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.36.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AN.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.28NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.221.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.242NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.160.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.449NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.152NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.146NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
D.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.81NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.64NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AH.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.327NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.396NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.129NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AK.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.20NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.221.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.224NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.14NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.29NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.510NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.91NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.227NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.555NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.513NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HN.4.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XACNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.1.1.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used